Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TLRY
TLRY logo

TLRY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.660
Open
5.650
VWAP
5.57
Vol
4.39M
Mkt Cap
665.00M
Low
5.475
Amount
24.44M
EV/EBITDA(TTM)
37.00
Total Shares
119.60M
EV
707.73M
EV/OCF(TTM)
--
P/S(TTM)
0.69
Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. Its adult-use portfolio offers a range of products, from flowers to beverages. Its beverage-alcohol portfolio includes a selection of craft beer, spirits, and beverages.
Show More

Events Timeline

(ET)
2026-04-23
13:10:00
Roth Capital: Cannabis Products Rescheduled to Schedule 3
select
2026-04-23
10:30:00
Trump Orders Medical Marijuana Products to Schedule III
select
2026-04-23
10:00:00
Trump Signs Order to Reschedule Medical Marijuana to Schedule III
select
link
2026-04-22 (ET)
2026-04-22
12:00:00
Trump Administration Expected to Reclassify Cannabis on Wednesday
select
link
2026-04-22
12:00:00
Tilray Trading Resumes
select
2026-04-22
11:50:00
Tilray Trading Halted Due to High Volatility
select

News

Fool
9.5
05-07Fool
PinnedTilray Brands Stock Fluctuations and Analyst Ratings
  • Price Volatility: Tilray Brands' stock surged recently due to U.S. legalization catalysts but subsequently fell below $6 from nearly $8 as investors reassessed the details, indicating market caution regarding short-term prospects.
  • Analyst Rating Upgrade: Following Tilray's latest quarterly earnings release, Roth Capital's William Kirk upgraded the stock from 'neutral' to 'buy' while maintaining a $10 price target, reflecting optimism about the stock's future.
  • International Market Growth: Tilray's international cannabis sales grew 73% year-over-year, demonstrating the company's successful penetration into markets outside North America, which may support future revenue growth.
  • Domestic Market Pressure: The ability of Canadian companies to export products has alleviated price pressure in the domestic market; however, Tilray's beverage unit is experiencing declining revenue and gross profits, and the company continues to report a net loss, highlighting ongoing challenges.
Fool
8.5
05-06Fool
Tilray Brands Faces Challenges and Opportunities
  • Market Outlook Positive: The cannabis market is projected to continue expanding, particularly in North America, with the cannabis beverage market valued at approximately $7.4 billion in 2023 and expected to grow to $242.68 billion by 2034, representing a compound annual growth rate of 54.62%, presenting potential growth opportunities for Tilray.
  • Diversified Revenue Structure: Tilray holds a leading market share in Canada, with its beverage segment accounting for 20% to 30% of quarterly revenue, and has established a strong brand network in the U.S. market through acquisitions, enhancing its competitive position in the cannabis beverage sector.
  • Challenges Ahead: Despite Tilray's leading position in the beverage category, the uncertainty surrounding federal legalization of cannabis in the U.S. remains, and the company's poor financial performance in recent years, characterized by inconsistent revenue growth and ongoing losses, has undermined investor confidence.
  • Increased Competitive Pressure: Should cannabis become legal at the federal level in the U.S., Tilray will face competition from cash-rich beverage giants with extensive experience in highly regulated consumer goods, which could threaten Tilray's market share and profitability.
NASDAQ.COM
7.5
05-06NASDAQ.COM
Tilray Brands Faces Opportunities and Challenges in Beverage Market
  • Market Potential: The cannabis beverage market is projected to be worth approximately $7.4 billion in 2023 and could grow to $242.68 billion by 2034, representing a compound annual growth rate of 54.62%, presenting significant opportunities for Tilray.
  • Revenue Structure: Tilray's beverage segment accounts for 20% to 30% of its quarterly revenue in Canada, and it has established itself as the fourth-largest craft brewer in the U.S. through acquisitions, indicating strong competitive positioning in the beverage market.
  • Legal Risks and Opportunities: While marijuana remains illegal at the federal level in the U.S., any changes in the next eight years could benefit Tilray; however, this may also lead to fierce competition from large beverage companies.
  • Poor Financial Performance: Tilray has faced significant financial challenges with consistent net losses and inconsistent revenue growth in recent years, and although its forward price-to-sales ratio of 0.7 suggests it may be undervalued, market confidence remains low.
stocktwits
7.5
05-06stocktwits
Tilray's BrewDog Partnership Raises Investor Concerns Amid Cannabis Focus Shift
  • Partnership Announcement: Tilray's 12-month partnership with BrewDog covers major U.K. festivals, including the Edinburgh Fringe, raising investor concerns about the company's shift towards beer production rather than cannabis.
  • Stock Decline: Tilray's shares fell 4% to $5.69 on Tuesday, marking a nine-month low, reflecting investor anxiety over the company's strategic direction, particularly as its stock has dropped 37% year-to-date.
  • Market Positioning Issues: Despite the U.S. government's rescheduling of marijuana, Tilray has no THC operations in the U.S., with the CEO acknowledging a strategic pivot towards beer and beverages, which has diminished investor confidence in its core cannabis business.
  • Global Expansion Strategy: Following the acquisition of BrewDog, Tilray aims to build a global beverage platform generating $500 million in annual revenue, with the CEO highlighting the company's status as the fourth-largest craft brewer in the U.S. and its significant brand presence worldwide.
Fool
8.5
05-04Fool
Marijuana Stocks Surge Then Fall Back
  • Short-Lived Surge: Tilray Brands' stock price briefly rose from around $7 to $8 on April 22 due to the DOJ's plans to reschedule marijuana, but quickly fell back to approximately $6, indicating significant market volatility.
  • Market Reaction: The spike is seen as a classic case of 'buy the rumor, sell the news,' as the market shifted from bullish to bearish, reflecting investor caution regarding the cannabis industry's future prospects.
  • Rescheduling Impact: While rescheduling moves marijuana from Schedule I to Schedule III, aligning it with prescription drugs, this change alone won't benefit companies like Tilray without full legalization, as the current rescheduling only applies to FDA-approved medical products.
  • Company Challenges: Tilray continues to face persistent losses and poor performance in its cannabis-infused beverages, and while rescheduling could offer tax relief, the slow regulatory progress necessitates a cautious approach for investors considering this high-risk growth stock.
NASDAQ.COM
8.5
05-04NASDAQ.COM
Tilray Stock Volatility Amid Regulatory Developments
  • Stock Volatility: Tilray's stock briefly surged from around $7 to $8 on April 22 due to the U.S. Department of Justice's plans to reschedule marijuana, but quickly fell back to nearly $6, indicating the market's sensitivity to regulatory news.
  • Regulatory Developments: While rescheduling moves marijuana from Schedule I to Schedule III, it does not immediately open the U.S. market for companies like Tilray, reflecting a cautious market sentiment regarding the implications of this announcement.
  • Tax Implications: The rescheduling will exempt Tilray and other cannabis companies from Section 280E tax rules, allowing for regular expense deductions; however, full legalization remains essential for significant business growth, and current regulatory progress is slow.
  • Market Outlook: Given the slow regulatory advancements and Tilray's ongoing losses, analysts recommend investors remain on the sidelines with this risky growth stock, especially considering the poor performance of Tilray's cannabis-infused beverages, which could continue to weigh on share prices.
Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
Wall Street analysts forecast TLRY stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
8.50
Averages
9.57
High
10.00
Current: 0.000
sliders
Low
8.50
Averages
9.57
High
10.00
Canaccord
Hold
downgrade
$13
AI Analysis
2026-04-02
Reason
Canaccord
Price Target
$13
AI Analysis
2026-04-02
downgrade
Hold
Reason
Canaccord lowered the firm's price target on Tilray to C$9.50 from C$13 and keeps a Hold rating on the shares.
Roth Capital
Bill Kirk
Neutral
to
Buy
upgrade
$10
2026-04-01
Reason
Roth Capital
Bill Kirk
Price Target
$10
2026-04-01
upgrade
Neutral
to
Buy
Reason
Roth Capital analyst Bill Kirk upgraded Tilray to Buy from Neutral with an unchanged $10 price target. The firm is citing the company's core Canadian business holding steady, inflection in Tilray's international operations and improving beverage category, the analyst tells investors in a research note. Tilray shares are back at July 2025 levels, but the fundamental outlook has improved and the potential for regulatory change is greater, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TLRY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Tilray Brands Inc (TLRY.O) is 1000.00, compared to its 5-year average forward P/E of 61.17. For a more detailed relative valuation and DCF analysis to assess Tilray Brands Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
61.17
Current PE
1000.00
Overvalued PE
360.38
Undervalued PE
-238.03

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
36.81
Current EV/EBITDA
-1.67
Overvalued EV/EBITDA
76.21
Undervalued EV/EBITDA
-2.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.00
Current PS
0.61
Overvalued PS
5.86
Undervalued PS
0.14

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

how is cannibis securities doing today
Intellectia · 8 candidates
Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
CGC logo
CGC
Canopy Growth Corp
511.04M
TLRY logo
TLRY
Tilray Brands Inc
803.02M
SNDL logo
SNDL
SNDL Inc
391.39M
VFF logo
VFF
Village Farms International Inc
328.97M
ACB logo
ACB
Aurora Cannabis Inc
201.89M
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.49B
best day trade stock
Intellectia · 9 candidates
Price: $5.00 - $100.00Volume: >= 3,000,000Price Change Pct: >= $3.00Relative Vol: >= 2Beta: HighRisk
Ticker
Name
Market Cap$
top bottom
KODK logo
KODK
Eastman Kodak Co
1.10B
ORIC logo
ORIC
Oric Pharmaceuticals Inc
995.75M
LUNR logo
LUNR
Intuitive Machines Inc
5.20B
RLAY logo
RLAY
Relay Therapeutics Inc
2.24B
GSAT logo
GSAT
Globalstar Inc
10.00B
AEHR logo
AEHR
Aehr Test Systems
1.36B
what penny stocks to buy pre market 4/1/26
Intellectia · 14 candidates
Market Cap: 100.00M - 2.00BRegion: USVolume: >= 200,000Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEPre Market Price Change: $3.00 - $20.00
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
753.80M
OMER logo
OMER
Omeros Corp
748.71M
VOR logo
VOR
Vor Biopharma Inc
871.44M
VALN logo
VALN
Valneva SE
542.98M
SLNO logo
SLNO
Soleno Therapeutics Inc
1.73B
SGMO logo
SGMO
Sangamo Therapeutics Inc
102.28M
Give me the top 5 cannabis companies
Intellectia · 4 candidates
Market Cap: >= 500.00MRevenue Ttm: >= 100.00MRegion: USThemes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.52B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.43B
CRON logo
CRON
Cronos Group Inc
947.63M
TLRY logo
TLRY
Tilray Brands Inc
736.32M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
what cannabis stocks would you buy?
Intellectia · 4 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
SNDL logo
SNDL
SNDL Inc
386.25M
ACB logo
ACB
Aurora Cannabis Inc
204.15M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
which. cannabisindustry should I invest in
Intellectia · 2 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
Cannibus stocks
Intellectia · 4 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryBeta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M

Whales Holding TLRY

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Tilray Brands Inc (TLRY) stock price today?

The current price of TLRY is 5.56 USD — it has decreased -1.77

What is Tilray Brands Inc (TLRY)'s business?

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. Its adult-use portfolio offers a range of products, from flowers to beverages. Its beverage-alcohol portfolio includes a selection of craft beer, spirits, and beverages.

What is the price predicton of TLRY Stock?

Wall Street analysts forecast TLRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is9.57 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Tilray Brands Inc (TLRY)'s revenue for the last quarter?

Tilray Brands Inc revenue for the last quarter amounts to 206.73M USD, increased 11.28

What is Tilray Brands Inc (TLRY)'s earnings per share (EPS) for the last quarter?

Tilray Brands Inc. EPS for the last quarter amounts to -0.24 USD, decreased -97.24

How many employees does Tilray Brands Inc (TLRY). have?

Tilray Brands Inc (TLRY) has 2842 emplpoyees as of May 10 2026.

What is Tilray Brands Inc (TLRY) market cap?

Today TLRY has the market capitalization of 665.00M USD.